Upcoming Events
PBBS San Diego 2024
April 30, 2024, 8:45am - 5:30pm in San Diego, CA
In-Person Workshop: Small Molecule Preclinical Development and IND Filing: Nuts, Bolts and Best Practices. Investigational new drug (IND) application is an important milestone that marks the entry of a molecule into clinical development. Knowing the objectives, expectations, and processes of assembling and filing an IND is the key to not only a successful filing but also a promising clinical development path forward.
Brews & Bioavailability Happy Hour at CPhl North America 2024
Wednesday, May 8th, 6-9pm at McGillen's Olde Ale House, Philadelphia, PA
Hosted by AustinPx, GL Chemtec, Microsize, and The Solubility Company. Brews are on us during our Brews & Bioavailability Happy Hour. RSVP via the link below. We look forward to seeing you there!
Past Events
Interphex 2024
April 16-18, 2024 in New York City
AustinPx will be showcasing The KinetiSol™ Technology equipment at this year’s Interphex. Elizabeth Hickman, CBO, Chris Brough, CTO, Rob Rigney, Sr. Director of Business Development, and Angie Hoffnagle, Marketing Director, will be in New York for Interphex. Schedule a meeting with them to learn more about the next generation amorphous dispersion technology.
Texas Life Sciences Summit 2024
April 2, 2024 at the Omni Austin Hotel Downtown
AustinPx is an exhibitor at the 2024 Texas Life Sciences Summit. The Texas Life Summit brings together state leaders, life science companies, economic development organizations, academic institutions, and service providers that support the ecosystem.
AAPS Northeast Regional Discussion Group 2024
March 22, 2024 in Groton, Connecticut
The purpose of the AAPS Northeast Regional Discussion Group (NERDG) is to: Foster education in and knowledge of the pharmaceutical sciences; Provide a local forum at which all scientists interested in the advancement of the pharmaceutical sciences may meet in professional and personal fellowship; and Share the scientific interests of researchers within the northeastern United States. Early registration ends on 8th March 2024.
DCAT Week 2024
March 18- 21, 2024 in New York City
The speed, flexibility, and knowhow to accelerate your drug candidate’s path to the clinic or market. Elizabeth Hickman, CBO, Rob Rigney, Sr. Director of Business Development, and Angie Hoffnagle, Marketing Director, will be in New York for DCAT week. Schedule a meeting with them to discuss your CMC and product development needs at one of the conferences.
Austin BioBash 2024
February 8, 2024, 6-9PM, Highpoint in Austin, TX
AustinPx is a proud sponsor of BioAustinCTX's BioBash on February 8, 2024. At this BioBash, the focus is on the development of Incubators in Central Texas and how they help improve and promote growth in the Life Science industry. We hope you are able to join AustinPx for a great night of learning and networking. Registration fee is just $20.
JP Morgan HealthCare Conference Week
January 8 - 11, 2024 in San Francisco
From accelerated development to bioavailability enhancement, AustinPx has the tools to help unlock the full potential of your molecule. Tim Scott, CEO, Elizabeth Hickman, CBO, and Collin Burger, Sr. Director of Business Development, will be in San Francisco for JP Morgan week, including RESI and Biotech Showcase. Schedule a meeting with them to discuss your CMC and product development needs at one of the conferences.
Drinks, Dinner, and Dispersions at Glass House, Cambridge MA
December 13th, 2023, 4:30-7:00pm
KinetiSol is a game-changing, commercially ready technology that is revolutionizing amorphous dispersions development and manufacturing. With its significantly smaller environmental and commercial footprint, broader formulation design space, rapid processing and easier scale up, KinetiSol is a better, faster and lower cost solution compared to spray drying. This presentation will showcase how KinetiSol has replicated and improved upon the bioavailability, manufacturability, and ecological footprint of spray dried dispersion drugs.
During the discussion, we will contrast the facility, utilities, and down stream processing requirements for KinetiSol compared to spray drying. Finally, we will dive into the biopharmaceutical performance benefits achievable with KinetiSol. These benefits will be demonstrated by a series of case studies and explained with data. By the end of the lecture, you will wonder why you ever developed your drug on a spray dryer.
The presentation, by AustinPx CSO Dave Miller, PhD will be approximately 30 minutes while guestes enjoy delectable appetizers and beverages. The presentation will be followed by a sit-down dinner.